US Patent No. 9,470,694

Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
Oct 20, 2016

Litron Laboratories has been awarded US Patent No. 9,470,694, "Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations."

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.

Oct
11
Sponsored by
ArcherDX

This webinar will discuss a validation study for a next-generation sequencing (NGS) assay for hematological malignancies (e.g., acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms).